Latest evidence-based view
ETN · BUY
ETN: the available evidence currently favors buying. 1 month +7.39% · 3 months +4.53% · 1 year +19.09% · Revenue vs. last year +15.53% · Profit per share vs. last year -1.12%.
ETN: the available evidence currently favors buying.
1 month +7.39% · 3 months +4.53% · 1 year +19.09% · Revenue vs. last year +15.53% · Profit per share vs. last year -1.12%. Taken together, the verified indicators provide stronger positive evidence.
Weaker indicators could change the assessment, but the current balance of evidence favors buying.
Buy in stages rather than all at once, and review your position if the three-month trend weakens.